Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine · Delayed Price · Currency is JOD · Price in USD

3.910

+0.060 (1.56%)

At close: Nov 12, 2026

PEX:BPC Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	47.19	47.96	40.65	43.13	47.03	45.47
Revenue Growth	1.35%	17.98%	-5.74%	-8.31%	3.44%	26.82%
Gross Profit	19.8	17.45	13.19	14.97	16.91	17.33
Operating Income	11.92	10.72	7.64	7.18	9.56	10.31
Net Income	11.1	11.95	5.18	6.12	7.95	12.08
Earnings Per Share	0.29	0.31	0.13	0.16	0.21	0.31
EPS Growth	-11.78%	130.54%	-15.26%	-24.77%	-32.60%	63.91%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	5.04	4.78	15.5	17.19	16.63	13.81
Total Debt	1.22	-	-	-	1.22	2.03
Net Cash (Debt)	3.82	4.78	15.5	17.19	15.41	11.78
Net Cash Growth	-9.93%	-69.17%	-9.81%	11.53%	30.87%	24.09%
Net Cash Per Share	0.10	0.12	0.40	0.44	0.41	0.30

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2.05	2.34	6.96	12.16	5.21	3.65
Capital Expenditures	-1.71	-2.33	-1.52	-3.33	-3.59	-0.93
Free Cash Flow	0.34	0	5.43	8.83	1.62	2.72
Free Cash Flow Growth	-83.43%	-99.93%	-38.45%	446.04%	-40.51%	-47.00%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	41.95%	36.38%	32.45%	34.71%	35.94%	38.11%
Operating Margin	25.25%	22.35%	18.80%	16.65%	20.32%	22.68%
Pretax Margin	26.93%	27.28%	14.90%	16.23%	19.19%	29.42%
Profit Margin	23.51%	24.91%	12.75%	14.18%	16.90%	26.56%
FCF Margin	0.73%	0.01%	13.37%	20.47%	3.44%	5.98%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.035	0.050	0.050	0.050	0.100	0.050
Dividend Per Share Growth	0%	0%	0%	-50.00%	100.00%	-31.97%
Dividend Yield	1.28%	1.12%	1.15%	1.14%	2.06%	1.77%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.57	14.44	32.54	27.70	21.51	9.07
P/FCF Ratio	440.44	43905.27	31.03	19.18	105.72	40.29
PS Ratio	3.21	3.60	4.15	3.93	3.64	2.41